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Background: Race and sex have been shown to affect management of myocardial infarction, however it is unclear if disparities exist in 
contemporary guideline driven care of both ST-elevation Myocardial Infarction (STEMI) and non-ST-elevation Myocardial Infarction (NSTEMI).
Methods: Data were collected from the ACTION Registry®-GWTG™ to identify care differences as related to race and sex of patients presenting 
with NSTEMI and STEMI. Characteristics were compared using Pearson Chi-Square testing for categorical variables and Kruskal-Walis testing for 
continuous variables.
Results: 175,370 patients from 464 US hospitals between July 1, 2008 to March 31, 2011 for whom race information was available were included. 
Key demographic variables (table) demonstrate that black patients had higher incidences of hypertension and diabetes and women more often had 
diabetes. There were notable differences in age across all groups. Presentation with STEMI was less common among both women and black patients. 
Disparities in care by race and sex were most pronounced for time to intervention and use of invasive management for NSTEMI. Disparities were less 
evident for use of primary PCI for STEMI and standard medications including aspirin and statins.
Conclusions: In this contemporary cohort, significant disparities in presentation and management of MI persist both by sex and race. However, 
heavily protocol driven processes such as PCI for STEMI seem to show fewer racial and sex disparities than NSTEMI care. 
White Male
103,194 (59%)
Black Male
10,179 (6%)
White Female
54,012 (31%)
Black Female
7,985
(5%)
P-Value
Unadjusted
Median Age,y 62 58 71 63 <0.0001
Median BMI (kg/m^2) 29 28 28 30 <0.0001
Diabetes, (%) 28 35 33 47 <0.0001
Hypertension, (%) 68 80 76 88 <0.0001
Prior MI, (%) 27 28 23 26 <0.0001
STEMI (%) 43 38 35 29 <0.0001
ASA w/in 24 hrs (%) 98 97 97 96 <0.0001
Statin w/in 24 hrs (%) 67 64 60 61 <0.0001
Primary PCI for STEMI (%) 86 86 85 85 0.002
PCI for NSTEMI (%) 52 45 40 37 <0.0001
Cath w/in 48 h (NSTEMI, %) 71 63 58 53 <0.0001
Median Arrival to PCI (NSTEMI, hrs)* 19 22 21 26 <0.0001
Discharge ASA (%) 98 97 97 96 <0.0001
Discharge Statin (%) 93 90 88 88 <0,0001
Death 4.1 4.1 5.8 5.8 <0.0001
Major Bleeding 7.8 8.4 13 14 <0.0001
